Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Celgene

Clinical trials sponsored by Celgene, explained in plain language.

Now part of Bristol-Myers Squibb BMY NYSE

A biopharmaceutical company focused on cancer and inflammatory diseases, now part of Bristol-Myers Squibb.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 10 Not yet recruiting 1 Not yet finished but already full! 10 Completed 13 Terminated 9

First human study of BMS-986368 begins in healthy chinese volunteers

Knowledge-focused Not yet recruiting

This phase 1 trial tests an experimental drug called BMS-986368 in 16 healthy Chinese adults. The main goal is to measure how the drug moves through the body and to check for any side effects. Participants receive either the drug or a placebo, and researchers monitor safety throu…

Phase: PHASE1 • Sponsor: Celgene • Aim: Knowledge-focused

Last updated Jul 16, 2026 00:00 UTC